Ken Moseley, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 27,646 shares at $12.26 ($339K) on 2017-07-13, disclosed to the SEC on 2017-07-17.
Open-market sale of $339k BLCM by Senior VP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.26 | 13,823 | $169K | 50.0% |
| 2 | $12.26 | 13,823 | $169K | 50.0% |
| Total | $12.26 avg | 27,646 | $339K | 100% |
| Filing → |
| BLCM | SELL | 2016-08-17 | $20K | — | Filing → |
| BLCM | SELL | 2016-06-06 | $195K | — | Filing → |
| BLCM | SELL | 2015-11-04 | $195K | — | Filing → |